// App-Quantinova.ai

TCT-787 : High-Sensitive Cardiac Troponin Predicts 2-years Mortality in Patients with Coronary Artery Disease- subanalysis of the GLOBAL LEADERS trial

Researchers

Presenter

  • Chun Chin Chang

Principal Investigators

  • Ply Chichareon

  • Norihiro Kogame

  • Rodrigo Modolo

  • Kuniaki Takahashi

  • Angel Cequier

  • Didier Carrie

  • Rod Stables

  • Kees-Jan Royaards

  • Jürgen vom Dahl

  • Yoshinobu Onuma

  • Christian Hamm

  • Pascal Vranckx

  • Marco Valgimigli

  • Stephan Windecker

  • Patrick Serruys

Medical Centers

  • Academic Medical Center, Amsterdam, Netherlands

  • Maasstad Hospital, Rotterdam, Netherlands

  • Imperial College, London, United Kingdom

  • Kerckhoff Clinic, Bad Nauheim, Germany

  • Bellvitge University Hospital, Barcelona, Spain

  • Thorax Center, Erasmus Medical Center, Rotterdam, Netherlands

  • Swiss Cardiovascular Center, Inselpsital, Bern, Switzerland

  • Hartcentre Hasselt, Hasselt, Belgium

  • Kliniken Maria Hilf, Mönchengladbach, Germany

  • Rangueil Hospital Toulouse, Toulouse, France

  • Liverpool Heart & Chest Hospital, Liverpool, United Kingdom.

  • University Hospital of Bern, Bern, Switzerland

Locations

  • Netherlands

  • France

  • United Kingdom

  • Switzerland

  • Spain

  • Germany

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Coronary Artery Disease

  • Myocardial infarction

  • Angina

Biomarkers

  • N/A

Drug/Treatment

  • Biolimus A9

  • Ticagrelor

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved